Series B - Karyopharm Therapeutics - Jul 31, 2013 Funding Round Profile - Cointime

Bitcoin $62,070.81 +2.34%
Ethereum $2,412.48 -0.23%
BNB $554.14 +0.26%
Optimism $1.56 +0.95%
Arbitrum $0.54 +0.97%
Solana $136.35 -0.64%
Polygon $0.39 +2.70%
Cosmos $4.24 +1.23%
Avalanche $24.74 -0.43%

Bitcoin $62,070.81 +2.34%
Ethereum $2,412.48 -0.23%
BNB $554.14 +0.26%
Optimism $1.56 +0.95%
Arbitrum $0.54 +0.97%
Solana $136.35 -0.64%
Polygon $0.39 +2.70%
Cosmos $4.24 +1.23%
Avalanche $24.74 -0.43%

Karyopharm Therapeutics

company

Funding Round

Series B

Money Raised

$ 19M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Foresite Capital	-	Yes	-	Detail
Delphi Ventures	-	-	-	Detail
New Leaf Venture Partners	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
May 20, 2013	Series B	$ 48.20M	Delphi Ventures	Detail
Nov 3, 2010	Series A	$ 20M		Detail
Jan 6, 2011	Grant	$ 1M	Multiple Myeloma Research Foundation	Detail
Nov 2, 2011	Series A	$ 10M	Chione	Detail